Shuanzeng Wei, Jianming Pei, Paul Belser, Teresa Lee, Jeffrey M. Farma, Arthur S. Patchefsky, Douglas B. Flieder, Elizabeth A. Montgomery
{"title":"在直肠肌样白肌瘤中发现新型 MIR143HG::PLAG1 基因融合体","authors":"Shuanzeng Wei, Jianming Pei, Paul Belser, Teresa Lee, Jeffrey M. Farma, Arthur S. Patchefsky, Douglas B. Flieder, Elizabeth A. Montgomery","doi":"10.1002/gcc.23239","DOIUrl":null,"url":null,"abstract":"<p>Myxoid leiomyosarcoma (MLS) is a rare but well-documented tumor that often portends a poor prognosis compared to the conventional leiomyosarcoma. This rare sarcoma has been reported in the uterus, external female genitalia, soft tissue, and other locations. However, a definite rectal MLS has not been reported. Recently five cases of MLS were reported to harbor <i>PLAG1</i> fusions (<i>TRPS1::PLAG1, RAD51B::PLAG1,</i> and <i>TRIM13::PLAG1</i>). In this report, we present a case of rectal MLS with a novel <i>MIR143HG::PLAG1</i> fusion detected by RNA next-generation sequencing.</p>","PeriodicalId":12700,"journal":{"name":"Genes, Chromosomes & Cancer","volume":"63 4","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Novel MIR143HG::PLAG1 gene fusion identified in a rectal myxoid leiomyosarcoma\",\"authors\":\"Shuanzeng Wei, Jianming Pei, Paul Belser, Teresa Lee, Jeffrey M. Farma, Arthur S. Patchefsky, Douglas B. Flieder, Elizabeth A. Montgomery\",\"doi\":\"10.1002/gcc.23239\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Myxoid leiomyosarcoma (MLS) is a rare but well-documented tumor that often portends a poor prognosis compared to the conventional leiomyosarcoma. This rare sarcoma has been reported in the uterus, external female genitalia, soft tissue, and other locations. However, a definite rectal MLS has not been reported. Recently five cases of MLS were reported to harbor <i>PLAG1</i> fusions (<i>TRPS1::PLAG1, RAD51B::PLAG1,</i> and <i>TRIM13::PLAG1</i>). In this report, we present a case of rectal MLS with a novel <i>MIR143HG::PLAG1</i> fusion detected by RNA next-generation sequencing.</p>\",\"PeriodicalId\":12700,\"journal\":{\"name\":\"Genes, Chromosomes & Cancer\",\"volume\":\"63 4\",\"pages\":\"\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2024-04-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Genes, Chromosomes & Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/gcc.23239\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GENETICS & HEREDITY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Genes, Chromosomes & Cancer","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/gcc.23239","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
Novel MIR143HG::PLAG1 gene fusion identified in a rectal myxoid leiomyosarcoma
Myxoid leiomyosarcoma (MLS) is a rare but well-documented tumor that often portends a poor prognosis compared to the conventional leiomyosarcoma. This rare sarcoma has been reported in the uterus, external female genitalia, soft tissue, and other locations. However, a definite rectal MLS has not been reported. Recently five cases of MLS were reported to harbor PLAG1 fusions (TRPS1::PLAG1, RAD51B::PLAG1, and TRIM13::PLAG1). In this report, we present a case of rectal MLS with a novel MIR143HG::PLAG1 fusion detected by RNA next-generation sequencing.
期刊介绍:
Genes, Chromosomes & Cancer will offer rapid publication of original full-length research articles, perspectives, reviews and letters to the editors on genetic analysis as related to the study of neoplasia. The main scope of the journal is to communicate new insights into the etiology and/or pathogenesis of neoplasia, as well as molecular and cellular findings of relevance for the management of cancer patients. While preference will be given to research utilizing analytical and functional approaches, descriptive studies and case reports will also be welcomed when they offer insights regarding basic biological mechanisms or the clinical management of neoplastic disorders.